104 related articles for article (PubMed ID: 16193085)
1. FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma.
Roncador G; Garcia JF; Garcia JF; Maestre L; Lucas E; Menarguez J; Ohshima K; Nakamura S; Banham AH; Piris MA
Leukemia; 2005 Dec; 19(12):2247-53. PubMed ID: 16193085
[TBL] [Abstract][Full Text] [Related]
2. Loss of Foxp3 is associated with CD30 expression in the anaplastic large cell subtype of adult T-cell leukemia/lymphoma (ATLL) in US/Caribbean patients: potential therapeutic implications for CD30 antibody-mediated therapy.
Yao J; Gottesman SR; Ayalew G; Braverman AS; Axiotis CA
Am J Surg Pathol; 2013 Sep; 37(9):1407-12. PubMed ID: 23797717
[TBL] [Abstract][Full Text] [Related]
3. Foxp3 expression on normal and leukemic CD4+CD25+ T cells implicated in human T-cell leukemia virus type-1 is inconsistent with Treg cells.
Abe M; Uchihashi K; Kazuto T; Osaka A; Yanagihara K; Tsukasaki K; Hasegawa H; Yamada Y; Kamihira S
Eur J Haematol; 2008 Sep; 81(3):209-17. PubMed ID: 18510697
[TBL] [Abstract][Full Text] [Related]
4. Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells.
Karube K; Ohshima K; Tsuchiya T; Yamaguchi T; Kawano R; Suzumiya J; Utsunomiya A; Harada M; Kikuchi M
Br J Haematol; 2004 Jul; 126(1):81-4. PubMed ID: 15198736
[TBL] [Abstract][Full Text] [Related]
5. Detection of Foxp3 protein expression in porcine T lymphocytes.
Käser T; Gerner W; Hammer SE; Patzl M; Saalmüller A
Vet Immunol Immunopathol; 2008 Sep; 125(1-2):92-101. PubMed ID: 18565594
[TBL] [Abstract][Full Text] [Related]
6. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
7. Adult T cell leukemia/lymphoma: FoxP3(+) cells and the cell-mediated immune response to HTLV-1.
Bangham CR; Toulza F
Adv Cancer Res; 2011; 111():163-82. PubMed ID: 21704832
[TBL] [Abstract][Full Text] [Related]
8. FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival.
Gjerdrum LM; Woetmann A; Odum N; Burton CM; Rossen K; Skovgaard GL; Ryder LP; Ralfkiaer E
Leukemia; 2007 Dec; 21(12):2512-8. PubMed ID: 17713545
[TBL] [Abstract][Full Text] [Related]
9. Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer.
Biller BJ; Elmslie RE; Burnett RC; Avery AC; Dow SW
Vet Immunol Immunopathol; 2007 Mar; 116(1-2):69-78. PubMed ID: 17224188
[TBL] [Abstract][Full Text] [Related]
10. Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast.
Leong PP; Mohammad R; Ibrahim N; Ithnin H; Abdullah M; Davis WC; Seow HF
Immunol Lett; 2006 Feb; 102(2):229-36. PubMed ID: 16246429
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
12. Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis.
Bonelli M; von Dalwigk K; Savitskaya A; Smolen JS; Scheinecker C
Ann Rheum Dis; 2008 May; 67(5):664-71. PubMed ID: 17728327
[TBL] [Abstract][Full Text] [Related]
13. Single-cell analysis of the human T regulatory population uncovers functional heterogeneity and instability within FOXP3+ cells.
d'Hennezel E; Yurchenko E; Sgouroudis E; Hay V; Piccirillo CA
J Immunol; 2011 Jun; 186(12):6788-97. PubMed ID: 21576508
[TBL] [Abstract][Full Text] [Related]
14. Sensitive detection of Foxp3 expression in bovine lymphocytes by flow cytometry.
Gerner W; Stadler M; Hammer SE; Klein D; Saalmüller A
Vet Immunol Immunopathol; 2010 Nov; 138(1-2):154-8. PubMed ID: 20701981
[TBL] [Abstract][Full Text] [Related]
15. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis.
Sugimoto N; Oida T; Hirota K; Nakamura K; Nomura T; Uchiyama T; Sakaguchi S
Int Immunol; 2006 Aug; 18(8):1197-209. PubMed ID: 16772372
[TBL] [Abstract][Full Text] [Related]
16. Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cells.
Felcht M; Heck M; Weiss C; Becker JC; Dippel E; Müller CS; Nashan D; Sachse MM; Nicolay JP; Booken N; Goerdt S; Klemke CD
Br J Dermatol; 2012 Aug; 167(2):348-58. PubMed ID: 22512270
[TBL] [Abstract][Full Text] [Related]
17. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells.
Yagi H; Nomura T; Nakamura K; Yamazaki S; Kitawaki T; Hori S; Maeda M; Onodera M; Uchiyama T; Fujii S; Sakaguchi S
Int Immunol; 2004 Nov; 16(11):1643-56. PubMed ID: 15466453
[TBL] [Abstract][Full Text] [Related]
18. The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-Cell leukemia/lymphoma.
Ishida T; Iida S; Akatsuka Y; Ishii T; Miyazaki M; Komatsu H; Inagaki H; Okada N; Fujita T; Shitara K; Akinaga S; Takahashi T; Utsunomiya A; Ueda R
Clin Cancer Res; 2004 Nov; 10(22):7529-39. PubMed ID: 15569983
[TBL] [Abstract][Full Text] [Related]
19. Impaired T cell receptor signaling in Foxp3+ CD4 T cells.
Carson BD; Ziegler SF
Ann N Y Acad Sci; 2007 Apr; 1103():167-78. PubMed ID: 17376831
[TBL] [Abstract][Full Text] [Related]
20. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections: a useful method for the diagnosis of lymphoblastic lymphoma.
Suzumiya J; Ohshima K; Kikuchi M; Takeshita M; Akamatsu M; Tashiro K
J Pathol; 1997 May; 182(1):86-91. PubMed ID: 9227346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
